Incyte said on Monday its experimental combo therapy helped patients with a type of blood cancer live longer without their ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or ...
Morning Overview on MSN
New research links cancer therapy and synthetic biology in a major leap
Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...
News-Medical.Net on MSN
Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer
Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...
A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...
The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...
Antineoplastons are a group of naturally occurring peptides and amino acid derivatives that may have potent anticancer properties. It is a unique and controversial therapy that emerged in the 1970s.
Martha Kinyonga was diagnosed with stage 4 colon cancer at age 38. Her community is now raising funds as she seeks a "last ...
Introduction Cancer care in humanitarian settings is very challenging, and patients may face significant barriers to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results